| Day Low 09:30 AM EDT | 10.28 | |
|---|---|---|
| Day High 10:43 AM EDT | 10.61 |
|
| Range | 0.34 | |
| Volume | 778,323 | |
| 30-Day Avg. Vol. | 925,000 |
|
| Difference | -15.86% | |
| Market Cap. | 880.3 M | |
| Change | 14.38 M | |
| Shares Out. | 84.64 M | |
| Percent Traded | 0.92% | |
| Revenue | 34.44 M | |
| Earnings | -86.88 M | |
| EPS (TTM) | -1.24 |
| 52-Wk Low 8/3/07 | 4.75 | |
|---|---|---|
| 52-Wk High 2/14/08 | 12.83 |
|
| Range | 8.08 | |
| Prev. Close 5/14/08 | 10.23 | |
| Today's Open | 10.28 | |
| Change | 0.49% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 2.16 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -5.00 |
Incyte hopes its success with inhibitors is uninhibited. The biotechnology company is focused on discovering and developing drugs that inhibit specific enzymes associated with cancer, diabetes, HIV, and ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.28 12/31/07 | -0.26 12/31/07 |
0.02
Beat
|
| Last Quarter | -0.47 3/31/08 | -0.47 3/31/08 |
0.004
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 1.31 M | 34.44 M |
| Gross Profit | -19.90 M | 34.44 M |
| Operating Income | -36.12 M | -85.48 M |
| Net Income | -40.16 M | -86.88 M |
